Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
published: 07 Jun 2013
last updated: 03 Aug 2020
No
JBK(S) 602-1/1/12 - CONFINED FIELD EVALUATION OF DELAYED RIPENING TRANSGENIC EKSOTIKA PAPAYA
EN
29 May 2013
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
No
No
-
Person:Dr. Rogayah SekeliPlant Transformation and Molecular Biologist, Biotechnology and Nanotechnology Research CentreMARDI Headquarters, Persiaran MARDI-UPMSerdang, Selangor
43400, MalaysiaPhone: +603 89537313,Fax:Email: lynn@mardi.gov.my,Website:Related OrganizationMalaysian Agricultural Research and Development Institute (MARDI)MARDI Headquarters, Persiaran MARDI-UPMSerdang, Selangor
43400, MalaysiaPhone: +603 89537313,Fax:Email: lynn@mardi.gov.my,Website:
Yes
No
No
Approval of the import and/or use of the LMO(s) with conditions
1) The Institutional Biosafety Committee (IBC) of MARDI shall ensure that the nethouse is inspected regularly to maintain the integrity of the nethouse and Standard Operating Procedures are complied with.
2) The National Biosafety Board shall be informed immediately if there is any containment breach or security breach in the confined field trial.
3) No parts of the GM papaya plants from this confined field trial shall be consumed or utilised for any other purpose other than this trial.
4) There shall be no planting of papaya plants within 1 km buffer zone from the nethouse, and all existing papaya plants in this zone shall be removed.
5) Should the approved person receive any scientifically proven information that confirms any adverse effect of transgenic Eksotika Papaya, the National Biosafety Board shall be informed.
EN
2) The National Biosafety Board shall be informed immediately if there is any containment breach or security breach in the confined field trial.
3) No parts of the GM papaya plants from this confined field trial shall be consumed or utilised for any other purpose other than this trial.
4) There shall be no planting of papaya plants within 1 km buffer zone from the nethouse, and all existing papaya plants in this zone shall be removed.
5) Should the approved person receive any scientifically proven information that confirms any adverse effect of transgenic Eksotika Papaya, the National Biosafety Board shall be informed.
This is to ensure that the confined field trial does not endanger biological diversity or human, animal and plant health.
EN
-
BCH-LMO-SCBD-104889-1 Living Modified Organism Papaya modified for delayed ripeningMalaysian Agricultural Research and Development Institute(MARDI) | Changes in physiology and/or production (Ripening), Resistance to antibiotics (Kanamycin)
-
BCH-RA-MY-104896-2 Risk Assessment generated by a regulatory process RISK ASSESSMENT REPORT OF THE GENETIC MODIFICATION ADVISORY COMMITTEE (GMAC) FOR AN APPLICATION FOR APPROVAL FOR CONFINED FIELD EVALUATION OF DELAYED RIPENING TRANSGENIC EKSOTIKA PAPAYAPapaya modified for delayed ripening | Papaya, Pawpaw, Papaw, CARPA, Resistance to antibiotics, Changes in physiology and/or production
- Department of Biosafety Malaysia [ English ]